• Roche and Pharmasset Join Forces to Develop New Generation of Hepatitis C Therapies
    NUTLEY, N.J. and ATLANTA -- Roche and Pharmasset announced a partnership to develop nucleoside polymerase inhibitors for the treatment of chronic hepatitis C virus (HCV) infections. Pharmasset will receive an upfront fee, research and development support and milestone ...More
    October 27, 2004 Posted in News
  • Smallpox: A Disease of the Past or a Weapon of Tomorrow?
    AMSTERDAM, The Netherlands -- Can this once eradicated killer return as a weapon of mass destruction?  Information published in this month's International Journal of Infectious Diseases discusses the potential return of smallpox -- one of the deadliest viruses known to ...More
    October 27, 2004 Posted in News
  • Bavarian Nordic Demonstrates Significant Progress to Provide World With Safe Smallpox Vaccine
    WASHINGTON and COPENHAGEN, Denmark -- International biopharmaceutical company Bavarian Nordic released its third quarter accomplishments relating to the development, production and marketing of innovative vaccines that prevent and treat infectious diseases. "The company's ...More
    October 27, 2004 Posted in News
  • Chiron Grants Nonexclusive HCV License to Roche
    EMERYVILLE, Calif. --Chiron Corporation announced that it has granted to F. Hoffmann-La Roche (Roche) a nonexclusive license for the research, development and commercialization of small molecule therapeutics against hepatitis C virus (HCV) drug targets. Under the terms of ...More
    October 27, 2004 Posted in News
  • WHO Launches World Alliance for Patient Safety
    The World Health Organization (WHO) and its partners announced a series of key actions to cut the number of illnesses, injuries and deaths suffered by patients during healthcare, with the launch of the World Alliance for Patient Safety. WHO, ministers of health and senior ...More
    October 27, 2004 Posted in News
  • Tool Reveals Molecular Signature of Cancer and HIV
    Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books. Preliminary studies in a small number of cell lines and body fluids show the ...More
    October 27, 2004 Posted in News
  • AORN Announces Perioperative QuizBowl Event for 2005 Congress
    The Perioperative QuizBowl will debut at the 2005 AORN Congress in April. This unparalleled, action-packed session will have a game show atmosphere, but will be unique to perioperative nursing. This general session will engage the audience and enhance everyone’s ...More
    October 27, 2004 Posted in News
  • RxAmerica to Team With ADAP to Help HIV-Positive Utahns
    SALT LAKE CITY -- The AIDS Drug Assistance Program (ADAP) of Utah announced it has chosen RxAmerica to manage its prescription benefit services. The HIV Treatment & Care Program is a federally funded drug assistance program, administered by the Utah Department of ...More
    October 26, 2004 Posted in News
  • Sontra Announces Promising Initial Human Clinical Results from Transdermal Vaccination Study
    FRANKLIN, Mass. -- Sontra Medical Corporation announced promising initial human clinical results from a twenty patient study conducted by Daniel H. Libraty, MD at the University of Massachusetts Medical School that evaluated the immune response induced by using the SonoPrep ...More
    October 26, 2004 Posted in News
  • Genetically Modified Parasite Lets Researchers Probe Immune System's Memory
    St. Louis -- Researchers at Washington University School of Medicine in St. Louis and the University of Pennsylvania have found an immune system cell can "remember" a parasite's attack and help the body mount a more effective defense against subsequent invasions by the same ...More
    October 26, 2004 Posted in News